1-6 of 6
Karissa Johnston
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Estimation of Relapsed/Refractory Follicular Lymphoma Patients on Therapy in the United States

Karissa Johnston, Mark Bennett, Savreet Bains Chawla, Shibing Yang, Anthony Wang, Junhua Yu, Monika Jun
Journal: Blood
Blood (2023) 142 (Supplement 1): 6148.
https://doi.org/10.1182/blood-2023-182030
Published: 2023
Journal Articles

Predictors for Improvement in Patient-Reported Outcomes: Post-Hoc Analysis of a Phase 3 Randomized, Open-Label Study of Eculizumab and Ravulizumab in Complement Inhibitor-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

Hubert Schrezenmeier, Austin G. Kulasekararaj, Lindsay Mitchell, Regis Peffault De Latour, Timothy Devos, Shinichiro Okamoto, Richard Wells, Karissa Johnston, Evan Popoff, Antoinette Cheung, Jimmy Wang, Philippe Gustovic, Alice Wang, Ioannis Tomazos, Yogesh Patel, Jong Wook Lee
Journal: Blood
Blood (2021) 138 (Supplement 1): 2196.
https://doi.org/10.1182/blood-2021-144554
Published: 2021
Journal Articles

A Matching-Adjusted Indirect Comparison of Nivolumab Versus Brentuximab Vedotin for Relapsed/Refractory Classical Hodgkin Lymphoma after Failure of Autologous Hematopoietic Cell Transplantation

Clara Chen, PhD BS, MS, Philippe Armand, MD PhD, Basia Rogula, Karissa Johnston, Derek Peterson, Joseph M Connors, MD, Greta Lozano-Ortega, MSc
Journal: Blood
Blood (2019) 134 (Supplement_1): 4761.
https://doi.org/10.1182/blood-2019-122302
Published: 2019
Journal Articles

Incremental Survival with Nivolumab Relative to Standard of Care in Classical Hodgkin Lymphoma: A Canadian Analysis

Greta Lozano-Ortega, MSc, Basia Rogula, Karissa Johnston, Julie Villeneuve, Andriy Moshyk, Heather O'Brien, Clara Chen, PhD BS, MS, Joseph M. Connors, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5894.
https://doi.org/10.1182/blood-2018-99-111278
Published: 2018
Journal Articles

Cost Effectiveness of Nivolumab for the Treatment of Relapsed/Refractory Classical Hodgkin Lymphoma (cHL) after Failure of Autologous Stem Cell Transplantation (ASCT) and Treatment with Brentuximab Vedotin (BV) Treatment in Australia

Marcus Tan, BPharm, Greta Lozano-Ortega, MSc, Shelagh Szabo, MSc, Karissa Johnston, PhD, Joseph M Connors, MD, Clara Chen, PhD BS, MS, Hansoo Kim
Journal: Blood
Blood (2017) 130 (Supplement 1): 2166.
https://doi.org/10.1182/blood.V130.Suppl_1.2166.2166
Published: 2017
Journal Articles

Economic Burden in US Patients with Relapsed or Refractory Classical Hodgkin Lymphoma Treated with Brentuximab Vedotin or Chemotherapy after Failure of Autologous Hematopoietic Cell Transplantation

Clara Chen, PhD BS, MS, Karissa Johnston, PhD, Shelagh Szabo, MSc, Joseph M Connors, MD, Christopher A. Yasenchak, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4705.
https://doi.org/10.1182/blood.V130.Suppl_1.4705.4705
Published: 2017